77 related articles for article (PubMed ID: 20617549)
1. Genes, the environment, and breast cancer.
Narod SA
Lancet; 2010 Jun; 375(9732):2123-4. PubMed ID: 20617549
[No Abstract] [Full Text] [Related]
2. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.
Hein R; Abbas S; Seibold P; Salazar R; Flesch-Janys D; Chang-Claude J
Breast Cancer Res Treat; 2012 Jan; 131(2):653-61. PubMed ID: 21947678
[TBL] [Abstract][Full Text] [Related]
4. [Breast cancer--a lifestyle disease?].
Kroman NT; Lidegaard Ø; Kvistgaard ME
Ugeskr Laeger; 2005 Dec; 167(49):4636-41. PubMed ID: 16336852
[TBL] [Abstract][Full Text] [Related]
5. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy.
Feigelson HS; McKean-Cowdin R; Pike MC; Coetzee GA; Kolonel LN; Nomura AM; Le Marchand L; Henderson BE
Cancer Res; 1999 Aug; 59(16):3908-10. PubMed ID: 10463580
[TBL] [Abstract][Full Text] [Related]
7. The role of polymorphisms in circadian pathway genes in breast tumorigenesis.
Dai H; Zhang L; Cao M; Song F; Zheng H; Zhu X; Wei Q; Zhang W; Chen K
Breast Cancer Res Treat; 2011 Jun; 127(2):531-40. PubMed ID: 20978934
[TBL] [Abstract][Full Text] [Related]
8. Common shared genetic variation behind decreased risk of breast cancer in celiac disease.
Ugalde-Morales E; Li J; Humphreys K; Ludvigsson JF; Yang H; Hall P; Czene K
Sci Rep; 2017 Jul; 7(1):5942. PubMed ID: 28725034
[TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase haplotype tag single-nucleotide polymorphisms and risk of breast cancer.
Martin YN; Olson JE; Ingle JN; Vierkant RA; Fredericksen ZS; Pankratz VS; Wu Y; Schaid DJ; Sellers TA; Weinshilboum RM
Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2322-4. PubMed ID: 17119067
[No Abstract] [Full Text] [Related]
10. Potential Impact of Vascular Endothelial Growth Factor Gene Variation (-2578C>A) on Breast Cancer Susceptibility in Saudi Arabia: a Case-Control Study.
Al Balawi IA; Mir R; Abu-Duhier FM
Asian Pac J Cancer Prev; 2018 Apr; 19(4):1135-1143. PubMed ID: 29699375
[TBL] [Abstract][Full Text] [Related]
11. Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects.
Ioannidis JP
J Natl Cancer Inst; 2006 Oct; 98(19):1350-3. PubMed ID: 17018776
[No Abstract] [Full Text] [Related]
12. Evaluation of CCL5 -403 G>A and CCR5 Δ32 gene polymorphisms in patients with breast cancer.
Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S; Bahari G; Mashhadi MA; Taheri M
Cancer Biomark; 2014; 14(5):343-51. PubMed ID: 25171476
[TBL] [Abstract][Full Text] [Related]
13. Genetic and environmental predictors, endogenous hormones and growth factors, and risk of estrogen receptor-positive breast cancer in Japanese women.
Yoshimoto N; Nishiyama T; Toyama T; Takahashi S; Shiraki N; Sugiura H; Endo Y; Iwasa M; Fujii Y; Yamashita H
Cancer Sci; 2011 Nov; 102(11):2065-72. PubMed ID: 21790896
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphism of SUMO-Specific Cysteine Proteases - SENP1 and SENP2 in Breast Cancer.
Mirecka A; Morawiec Z; Wozniak K
Pathol Oncol Res; 2016 Oct; 22(4):817-23. PubMed ID: 27178176
[TBL] [Abstract][Full Text] [Related]
15. [Breast cancer and hormone replacement therapy around menopause].
Franke HR; Schram JH; van der Mooren MJ
Ned Tijdschr Geneeskd; 2003 Sep; 147(39):1934-5; author reply 1935. PubMed ID: 14560695
[No Abstract] [Full Text] [Related]
16. Relationship between Genetic Polymorphisms in MTHFR (C677T, A1298C and their Haplotypes) and the Incidence Of Breast Cancer among Jordanian Females--Case-Control Study.
Awwad N; Yousef AM; Abuhaliema A; Abdalla I; Yousef M
Asian Pac J Cancer Prev; 2015; 16(12):5007-11. PubMed ID: 26163632
[TBL] [Abstract][Full Text] [Related]
17. Re: Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium.
Baker SG
J Natl Cancer Inst; 2007 Mar; 99(6):487-8; author reply 488-9. PubMed ID: 17374838
[No Abstract] [Full Text] [Related]
18. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study.
Jedlinski DJ; Gabrovska PN; Weinstein SR; Smith RA; Griffiths LR
Twin Res Hum Genet; 2011 Oct; 14(5):417-21. PubMed ID: 21962133
[TBL] [Abstract][Full Text] [Related]
19. Association between ERCC5 gene polymorphisms and breast cancer risk.
Na N; Dun E; Ren L; Li G
Int J Clin Exp Pathol; 2015; 8(3):3192-7. PubMed ID: 26045839
[TBL] [Abstract][Full Text] [Related]
20. Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
Cerne JZ; Novakovic S; Frkovic-Grazio S; Pohar-Perme M; Stegel V; Gersak K
Oncol Rep; 2011 Aug; 26(2):479-85. PubMed ID: 21567099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
